Finance

Lists
2126:HKG
JW (Cayman) Therapeutics Co Ltd
HK$2.19
+7.62%
(+0.15) 1D
Sep 17, 4:08:07 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2126...
Open
HK$2.04
High
HK$2.32
Low
HK$2.02
Mkt. cap
910.44M
Avg. vol.
0.00
Volume
3.61M
52-wk high
HK$5.25
52-wk low
HK$1.40
EPS
-HK$0.95
No. of employees
303
Open
HK$2.04
High
HK$2.32
Low
HK$2.02
Mkt. cap
910.44M
Avg. vol.
0.00
Volume
3.61M
52-wk high
HK$5.25
52-wk low
HK$1.40
EPS
-HK$0.95
No. of employees
303
About JW (Cayman) Therapeutics Co Ltd
CEOJames Li
Employees303
Founded2016
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
88.65M
88.65M
55.68M
55.68M
Cost of goods sold
34.67M
34.67M
26.82M
26.82M
Cost of revenue
34.67M
34.67M
26.82M
26.82M
Research and development expenses
48.17M
48.17M
24.91M
24.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
71.08M
71.08M
50.44M
50.44M
Operating expense
118.90M
118.90M
75.33M
75.33M
Total operating expenses
153.57M
153.57M
102.15M
102.15M
Operating income
-64.92M
-64.92M
-46.48M
-46.48M
Other non operating income
-
-
-
-
EBT including unusual items
-142.48M
-142.48M
-25.21M
-25.21M
EBT excluding unusual items
-41.35M
-41.35M
-25.21M
-25.21M
Income tax expense
1.53M
1.53M
-
-
Effective tax rate
-1.08%
-1.08%
-
-
Other operating expenses
-341.50K
-341.50K
-23.50K
-23.50K
Net income
-144.01M
-144.01M
-25.21M
-25.21M
Net profit margin
-162.45%
-162.45%
-45.28%
-45.28%
Earnings per share
-
-
-
-
Interest and investment income
4.27M
4.27M
1.99M
1.99M
Interest expense
-2.59M
-2.59M
-1.87M
-1.87M
Net interest expenses
1.67M
1.67M
115.50K
115.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-50.85M
-50.85M
-30.82M
-30.82M
Gain or loss from assets sale
35.50K
35.50K
-
-
AI content may include mistakes. Learn more
Google apps